Aditxt (ADTX) Change in Accured Expenses (2019 - 2026)
Aditxt (ADTX) recorded quarterly Change in Accured Expenses of -$562609.0 in Q1 2026, up 85.98% quarter-over-quarter from -$4.0 million in Q4 2025, and up 90.43% on a YoY basis from -$295439.9 in Q1 2025.
Aditxt (ADTX) Change in Accured Expenses (2019 - 2026) Analysis & Trends
Aditxt's Change in Accured Expenses history runs 8 years deep, the most recent figure standing at -$562609.0 for Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 90.43% year-over-year to -$562609.0; the TTM figure through Mar 2026 stood at -$316056.0 (up 85.15% YoY), while the FY2025 annual figure was -$5.6 million, down 210.56% from the prior year.
- Change in Accured Expenses was -$562609.0 for Q1 2026 at Aditxt, up from -$4.0 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $4.3 million in Q4 2023 to a low of -$5.9 million in Q1 2025.
- Historically, Change in Accured Expenses has averaged $350529.7 across 5 years, with a median of $983579.0 in 2022.
- Biggest YoY gain for Change in Accured Expenses was 842.96% in 2022; the steepest drop was 799.49% in 2022.
- A 5-year view of Change in Accured Expenses shows it stood at -$723489.0 in 2022, then surged by 698.56% to $4.3 million in 2023, then slumped by 134.02% to -$1.5 million in 2024, then tumbled by 172.33% to -$4.0 million in 2025, then jumped by 85.98% to -$562609.0 in 2026.
- The last three Change in Accured Expenses figures came in at -$562609.0 (Q1 2026), -$4.0 million (Q4 2025), and $931660.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 931,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 | -562,609.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -562,609.00 |
| Mar 31, 2026 | -562,609.00 |
| Dec 31, 2025 | -4.01 Mn |
| Dec 31, 2025 | -4.01 Mn |
| Sep 30, 2025 | 931,660.00 |
| Sep 30, 2025 | 931,660.00 |
| Jun 30, 2025 | 3.33 Mn |
| Jun 30, 2025 | 3.33 Mn |
| Mar 31, 2025 | -5.88 Mn |
| Mar 31, 2025 | -5.88 Mn |
| Dec 31, 2024 | -1.47 Mn |
| Dec 31, 2024 | -1.47 Mn |
| Sep 30, 2024 | 1.45 Mn |
| Sep 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | 3.78 Mn |
| Jun 30, 2024 | 3.78 Mn |
| Mar 31, 2024 | 1.34 Mn |
| Mar 31, 2024 | 1.34 Mn |
| Dec 31, 2023 | 4.33 Mn |
| Dec 31, 2023 | 4.33 Mn |